From: Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic
Number of naloxone prescriptions | p-value | Number of patients with OUD | p-value | |||
---|---|---|---|---|---|---|
Year | 2019 | 2020 | 2019 | 2020 | ||
Total | 609 | 619 | 2962 | 2641 | ||
Age (years) | ||||||
Mean (SD) | 44.4 ± 14.7a | 41.9 ± 12.6a | a | 43.4 ± 14.0 | 42.3 ± 13.5 | a |
Sex | ||||||
Female | 300 (49.3%) | 277 (44.7%) | 0.11 | 1461 (49.3%) | 1272 (48.2%) | 0.39 |
Male | 309 (50.7%) | 342 (55.3%) | 1501 (50.7%) | 1369 (51.8%) | ||
Race | ||||||
Black | 123 (20.2%) | 142 (22.9%) | 0.49 | 651 (22.0%) | 527 (20.0%) | 0.17 |
White | 472 (77.5%) | 462 (74.6%) | 2223 (82.58%) | 2030 (76.9%) | ||
Otherb | 14 (2.3%) | 15 (0.81%) | 88 (3.0%) | 84 (3.2%) | ||
Ethnicityc | ||||||
Non-Hispanic | 575 (94.4%) | 587 (94.8%) | 2829 (95.5%) | 2492 (94.4%) | ||
Hispanic | 3 (0.5%) | 2 (0.3%) | 13 (0.4%) | 16 (0.6%) | ||
Unknown | 31 (5.1%) | 30 (4.8%) | 120 (4.1%) | 133 (5.0%) | ||
Insurance | ||||||
Public | 295 (48.4%) | 251 (40.5%) | < 0.05 | 1101 (37.2%) | 943 (35.7%) | 0.23 |
Private | 112 (18.4%) | 94 (15.2%) | 761 (25.7%) | 659 (25.0%) | ||
Uninsured | 202 (33.2%) | 274 (44.3%) | 1100 (37.1%) | 1039 (39.3%) | ||
Encounter | ||||||
Emergency | 118 (19.4%) | 117 (18.9%) | < 0.05 | 1123 (37.9%) | 899 (34.0%) | < 0.05 |
Inpatient | 282 (46.3%) | 384 (62.0%) | 770 (26.0%) | 824 (31.2%) | ||
Outpatient | 209 (34.3%) | 118 (19.1%) | 1069 (36.1%) | 918 (34.8%) |